| Crystal structure of human CD38 ECD in complex with UniDab(TM) F11A | |
Heteromer
| 46-300 | 3×EDO; 1×CL; 1×NA; 1×MG; |
| Assess |
| crystal structure of CD38 in complex with daratumumab | |
Heteromer
| 48-300 | |
| Assess |
| human CD38 in complex with nanobody MU375 | |
Heteromer
| 49-300 | 2×SO4; 1×GOL; |
| Assess |
| human CD38 in complex with nanobody MU551 | |
Heteromer
| 49-296 | |
| Assess |
| human CD38 in complex with nanobody MU1053 | |
Heteromer
| 49-296 | |
| Assess |
| Crystal Structure of HexaBody-CD38 Fab in complex with CD38 | |
Heteromer
| 45-291 | 3×SO4; 2×GOL; 2×EDO; |
| Assess |
| Crystal structure of CD38 with a novel CD38-targeting antibody SAR650984 | |
Heteromer
| 48-287 | |
| Assess |
| Cryo-EM structure of CD38 in complex with FTL004 | |
Heteromer
| 48-279 | |
| Assess |
| Crystal structure of human CD38 in complex with the Fab fragment of antibody HB7 | |
Heteromer
| 50-279 | |
| Assess |
| Crystal structure of daratumumab fab and CD38 complex | |
Heteromer
| 57-285 | |
| Assess |
| Human CD38 ectodomain bound to a 78c-ADPR adduct | | homo-2-mer | 45-283 | 2×Q2C; |
| Assess |
| X-ray structure of human CD38 catalytic domain with 2'-Cl-araNAD+ | | monomer | 46-300 | 1×ROJ; 1×K; 1×PO4; 2×PEG; 1×MPD; 1×PGE; |
| Assess |
| Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38 | | monomer | 45-296 | 1×CXR; |
| Assess |
| Crystal structure of human CD38 extracellular domain, GTP complex | | monomer | 45-296 | 1×GTP; |
| Assess |
| Crystal structure of human CD38 extracellular domain, ara-F-ribose-5'-phosphate/nicotinamide complex | | monomer | 45-296 | 1×RF5; 1×NCA; |
| Assess |
| Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38 | | monomer | 45-296 | 1×CGR; |
| Assess |
| Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysis | | monomer | 45-296 | 2×G1R; |
| Assess |
| Catalysis associated conformational changes revealed by human cd38 complexed with a non-hydrolyzabl… | | monomer | 45-296 | 1×N1C; |
| Assess |
| Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysis | | monomer | 45-296 | 1×APR; |
| Assess |
| Crystal structure of human CD38 extracellular domain, ribose-5'-phosphate intermediate/GTP complex | | monomer | 45-296 | 1×RGT; |
| Assess |
| Crystal structure of human CD38 complexed with an analog ara-2'F-ADPR | | monomer | 45-296 | 1×AVU; |
| Assess |
| Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38 | | monomer | 45-296 | 1×CXR; |
| Assess |
| Catalysis associated conformational changes revealed by human CD38 complexed with a non-hydrolyzabl… | | monomer | 45-296 | 1×N1C; |
| Assess |
| Crystal structure of human CD38 extracellular domain, NMN complex | | monomer | 45-296 | 1×NMN; |
| Assess |
| Crystal structure of human CD38 extracellular domain E226Q mutant, NMN complex | | monomer | 45-296 | 1×NMN; |
| Assess |
| Crystal structure of human CD38 extracellular domain | | monomer | 45-296 | |
| Assess |
| Crystal structure of human CD38 in complex with compound CZ-50b | | monomer | 45-296 | 1×50A; 1×NCA; |
| Assess |
| Acidic residues at the active sites of CD38 and ADP-ribosyl cyclase determine NAAPD synthesis and h… | | monomer | 45-296 | 1×NMN; |
| Assess |
| Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38 | | monomer | 45-296 | 1×CXR; |
| Assess |
| Crystal structure of human CD38 extracellular domain complexed with a covalent intermediate, ara-F-… | | monomer | 45-296 | 1×RF5; |
| Assess |
| Crystal structure of human CD38 complexed with an analog ribo-2'F-ADP ribose | | monomer | 45-296 | 1×AVW; |
| Assess |
| Crystal structure of human CD38 in complex with compound CZ-48 | | monomer | 45-296 | 1×48Z; |
| Assess |
| Crystal structure of human CD38 in complex with compound CZ-46 | | monomer | 45-296 | 1×46Z; |
| Assess |
| Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38 | | monomer | 45-296 | 1×NGD; |
| Assess |
| CD38 structure-based inhibitor design using the N1-cyclic inosine 5'-diphosphate ribose template | | monomer | 45-296 | 1×CVR; |
| Assess |
| Crystal structure of human CD38: cyclic-ADP-ribosyl synthetase/NAD+ glycohydrolase | | monomer | 46-297 | 2×SO4; |
| Assess |
| Crystal structure of human CD38 in complex with compound CZ-27 | | monomer | 46-296 | 1×27C; |
| Assess |
| Crystal structure of human CD38 E226Q mutant in complex with NAADP | | monomer | 46-296 | 1×DN4; |
| Assess |
| CD38 structure-based inhibitor design using the N1-cyclic inosine 5'-diphosphate ribose template | | monomer | 48-296 | 1×C8R; |
| Assess |
| Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysis | | monomer | 48-296 | 1×NAD; |
| Assess |
| Structure of a human CD38 mutant complexed with NMN | | monomer | 46-293 | 1×NMN; |
| Assess |
| Crystal Structure of Human CD38 in Complex with 4'-Thioribose NAD+ | | monomer | 45-292 | 1×ZNA; |
| Assess |
| Crystal structure of human CD38 in complex with hydrolysed compound JMS713 | | monomer | 50-296 | 1×JS2; |
| Assess |
| Crystal structure of the extracellular domain of human CD38 | | monomer | 45-291 | 1×EPE; |
| Assess |
| Crystal structure of wild type human CD38 in complex with NAADP and ADPRP | | monomer | 46-291 | 1×DVN; |
| Assess |
| Human CD38 complexed with inhibitor 2 [4-[(2,6-dimethylbenzyl)amino]-2-methylquinoline-8-carboxamid… | | monomer | 46-290 | 1×41Z; 1×NA7; |
| Assess |
| Human CD38 complexed with inhibitor 1 [6-fluoro-2-methyl-4-[(2,3,6-trichlorobenzyl)amino]quinoline-… | | monomer | 46-288 | 1×733; 1×HSX; |
| Assess |
| HUMAN CD38 ECTODOMAIN BOUND TO COMPOUND 9-ADPR ADDUCT | | monomer | 46-286 | 1×X5T; |
| Assess |
| Dynamic conformations of the CD38-mediated NAD cyclization captured using multi-copy crystallography | | monomer | 46-281 | 1×AVU; |
| Assess |
| Conformational Closure of the Catalytic Site of Human CD38 Induced by Calcium | | monomer | 45-279 | 3×CA; |
| Assess |